Xenon Pharmaceuticals Inc XENE
$65.26
+3.23%
at last close
Market Cap$6.31 billion
P/E Ratio—
Div Yield—
Volume778.2K
52-Week Range
$30.00$72.66
Key Stats
- Today's Range
- $63.02 – $65.42
- 50-Day Range
- $50.91 – $72.66
- 52-Week Range
- $30.00 – $72.66
- Volume
- 778K shs
- Average Volume
- 1.07 million shs
- Market Cap
- $6.31 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.08
- Price / Sales
- —
Short Interest
- Short Interest
- 0.15%
- Days to Cover
- 1.11
Financials (TTM)
- Revenue
- —
- Net Income
- $-409,195,000
- Net Margin
- —
- Return on Equity
- -32.94%
- Debt-to-Equity
- —
About Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Related Stocks
Compare head-to-head: XENE vs LLY·XENE vs JNJ·XENE vs ABBV·XENE vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.